Aytu Biopharma Files Annual Report Form 10-K with SEC on October 12, 2023 for fiscal year ending June 30, 2023. Aytu Biopharma is exploring use of ultraviolet disinfection with Healight esophogeal explorative device.Full text of Form 10-K available at: https://tinyurl.com/ynmtsm4rCOMPANY OVERVIEWAytu BioPharma, Inc. (“Aytu,” the “Company”, “we”) is a pharmaceutical company focused on commercializing novel…
Aytu Biopharma Files Form 10-K Annual Report with SEC
More from InformationalMore posts in Informational »
- UV Business News – Veralto Files SEC Registration Form S-4 For Pending Stock Exchange
- Advanced Strategies For Mitigating Waterborne And Airborne Pathogens To Prevent Disease
- Limerick, Ireland Boil Water Notice Still In Place Even After UV Sterilizer Installed
- Degradation of Organic Materials In Nanofiltration Systems Using UV / Peroxysulfate / Ozone
- Textile Industry Wastewater Treatment System Embodies “Environmentally Friendly” UV 222 nm Irradiation